Skip to main content
RNAC logo

RNAC · Cartesian Therapeutics, Inc.

Track RNAC — free
$8.92 -0.35 (-3.78%)
Market Cap
$280.47M
Shares
30.26M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1453687 CUSIP 816212302 13F (30d) 65 filings 65 filers Visit website Investor relations